Separate terms with OR to return results that match either term.
 
Clear All
10,000 Matching Results — Export these results
Click column titles once to sort ascending, and twice to sort descending.
Show Entries
NDC-11 (Package) (Descending) NDC-9 (Product) Generic Name Brand Name Strength SEER*Rx Category Major Class Minor Class Administration Route Package Effective Date Package Discontinuation Date Status
75987-0111-11 75987-0111 Interferon gamma-1b Actimmune 100.0 ug/.5mL Immunotherapy Cytokine Interferon Subcutaneous Dec. 1, 2013 In Use
75987-0022-70 75987-0022 Prednisone Rayos 5.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral July 27, 2012 In Use
75987-0022-02 75987-0022 Prednisone Rayos 5.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral July 27, 2012 In Use
75987-0022-01 75987-0022 Prednisone Rayos 5.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral July 27, 2012 In Use
75987-0021-70 75987-0021 Prednisone Rayos 2.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral July 27, 2012 In Use
75987-0021-02 75987-0021 Prednisone Rayos 2.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral July 27, 2012 In Use
75987-0021-01 75987-0021 Prednisone Rayos 2.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral July 27, 2012 In Use
75987-0020-70 75987-0020 Prednisone Rayos 1.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral July 27, 2012 In Use
75987-0020-02 75987-0020 Prednisone Rayos 1.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral July 27, 2012 In Use
75987-0020-01 75987-0020 Prednisone Rayos 1.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral July 27, 2012 In Use
75929-0174-03 75929-0174 Belumosudil Rezurock 200.0 mg/1 Chemotherapy Rho Kinase Inhibitor ROCK 1, ROCK2 Oral July 16, 2021 In Use
75921-0459-10 75921-0459 Ondansetron Ondansetron 8.0 mg/1 Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral June 25, 2007 In Use
75907-0191-02 75907-0191 Cyclophosphamide CYCLOPHOSPHAMIDE 200.0 mg/mL Chemotherapy Alkylating Agent Nitrogen Mustard Intravenous June 20, 2024 In Use
75907-0190-07 75907-0190 cyclophosphamide CYCLOPHOSPHAMIDE 200.0 mg/mL Chemotherapy Alkylating Agent Nitrogen Mustard Intravenous June 20, 2024 In Use
75907-0189-35 75907-0189 Cyclophosphamide CYCLOPHOSPHAMIDE 200.0 mg/mL Chemotherapy Alkylating Agent Nitrogen Mustard Intravenous June 20, 2024 In Use
75907-0112-11 75907-0112 Melphalan Hydrochloride Melphalan Hydrochloride 50.0 mg/10ml Chemotherapy Alkylating Agent Nitrogen Mustard Intravenous June 26, 2024 In Use
75907-0095-40 75907-0095 FLUOROURACIL FLUOROURACIL 50.0 mg/g Chemotherapy Antimetabolite Pyrimidine Analog Topical April 15, 2024 In Use
75907-0047-30 75907-0047 Cyclosporine Cyclosporine 25.0 mg/1 Ancillary Therapy Immunomodulator Calcineurin Inhibitor Oral July 1, 2024 In Use
75840-0111-01 75840-0111 Methotrexate sodium Methotrexate Sodium 2.5 mg/1 Chemotherapy Antimetabolite Folic Acid Analog Oral Oct. 1, 2012 In Use
75840-0111-00 75840-0111 Methotrexate sodium Methotrexate Sodium 2.5 mg/1 Chemotherapy Antimetabolite Folic Acid Analog Oral Oct. 1, 2012 In Use
75834-0190-01 75834-0190 Decitabine Decitabine 50.0 mg/20mL Chemotherapy Antimetabolite Pyrimidine Analog Intravenous Dec. 17, 2020 In Use
75834-0146-05 75834-0146 Temozolomide Temozolomide 250.0 mg/1 Chemotherapy Alkylating Agent Tetrazine Oral Dec. 7, 2021 In Use
75834-0145-14 75834-0145 Temozolomide Temozolomide 180.0 mg/1 Chemotherapy Alkylating Agent Tetrazine Oral Dec. 7, 2021 In Use
75834-0145-05 75834-0145 Temozolomide Temozolomide 180.0 mg/1 Chemotherapy Alkylating Agent Tetrazine Oral Dec. 7, 2021 In Use
75834-0144-14 75834-0144 Temozolomide Temozolomide 140.0 mg/1 Chemotherapy Alkylating Agent Tetrazine Oral Dec. 7, 2021 In Use

Found 10,000 results in 3 milliseconds — Export these results